Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Radioactive Iodine Therapy
DRUG
4 trials
Sponsors
AstraZeneca
, Assiut University
Conditions
Cancer
Differentiated Thyroid Cancer
Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients
Phase 1
Empirical Radioactive Iodine Therapy in DTC
Not yet recruiting
NCT07453225
Assiut University
Differentiated Thyroid Cancer
Start: 2026-04-01
End: 2028-07-01
Target: 100
Updated: 2026-03-05
Phase 3
Comparing Complete Remission After Treatment With Selumetinib/Placebo in Patient With Differentiated Thyroid Cancer
Terminated
NCT01843062
AstraZeneca
Differentiated Thyroid Cancer
Start: 2013-08-27
End: 2019-03-06
Updated: 2019-08-28
Phase 4
Characterisation and management of differentiated thryoid cancer in South Africa
Active, not recruiting
PACTR202606600099760
Cancer
Start: 2026-06-01
Target: 100
Updated: 2026-09-14
Unknown Phase
Factors Affecting Timing of Hypothyroidism Following Radioactive Iodine Therapy Patients With Graves Disease
NCT05643365
Assiut University
Radioactive Iodine-Induced Hypothyroidism in Graves Disease Patients
Start: 2013-01-01
End: 2023-12-01
Target: 300
Updated: 2023-10-12
Related Papers
Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
Journal of Clinical Oncology
2022-02-22
59 citations